Major Pharmaceutical Companies Collaborate in Groundbreaking NCCN Project
National Comprehensive Cancer Network® (NCCN®)The NCCN Oncology Research Program has awarded grants for its first-ever multi-industry collaborative project, soliciting investigator-initiated proposals to research the effectiveness of Boehringer Ingelheim’s afatinib in combination with other drugs to treat lung and head and neck cancers.